KRTX News and Press, Karuna Therapeutics Inc. From 02/09/21

Karuna Therapeutics (KRTX) has ended the three-day winning streak to lose ~5.6% so far today despite the outperform rating initiated by RBC Capital Markets with a price target of $160.00 per share, ~27.5% upside to the previous close.The analyst Brian Abrahams and the team note the ...

Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will participate in a fireside chat at the 10 ...

Karuna's IPO in 2019 was the most successful of the year for a biotech in terms of share price growth. The company's lead and only asset - KarXT, indicated for Schizophrenia - surprised the market with best-in-class data causing shares to spike ~400%. Now the company has initiated...

Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the appointment of Ronald Marcus, M.D., to Senior Vice President of M...

The following slide deck was published by Karuna Therapeutics, Inc. in conjunction with this event. For further details see: Karuna Therapeutics (KRTX) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that Andrew Miller, Ph.D., chief operating officer and founder, will ...

Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that Steve Paul, M.D., chief executive officer, president and chairma...

Halvorsen's 13F portfolio value increased from $23.14B to $27.68B. The number of positions increased 71 to 86. Viking Global increased Microsoft, Mecadolibre, and CME Group while reducing Amazon.com and dropping Uber Technologies & JD.com. The top three positions are Microsoft...

Ed Harrigan, M.D., to step down from Karuna’s board and continue to serve on the Company’s scientific advisory board Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with th...

Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced that senior manag...